awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35788245-3311920A-1463-483F-BCB7-784F397AE7B4
Q35788245-3311920A-1463-483F-BCB7-784F397AE7B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35788245-3311920A-1463-483F-BCB7-784F397AE7B4
The development of potential antibody-based therapies for myeloma
P2860
Q35788245-3311920A-1463-483F-BCB7-784F397AE7B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35788245-3311920A-1463-483F-BCB7-784F397AE7B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e338db1a6e33f3c92be5d663dd771d227bc3834
P2860
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma